USPTO serial 79241986
MEDI-SOLFEN
Reviewed by CopyMark Law Group
Reg. 5905700Status 709
- Filing date
- Status date
- Registration date
- Nov 12, 2019
- Examiner
- MAHMOUDI, MARIAM AZIZ
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MEDI-SOLFEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marcus N. DiBuduo
Marcus N. DiBuduo Fennemore Craig, P.C.8080 N. Palm Ave., Third FloorFresno, CA 93711UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Sanitary preparations for medical purposes; medical plasters; wound dressings; medical dressings; medical dressings impregnated with pharmaceutical preparations in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; dressings for skin traumas; dressings for wounds; surgical dressings; surgical dressings being absorbable by the body; surgical dressings impregnated with substances to increase the rate of healing of the wounds in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; wound dressing substances, namely, wadding and gauzes; bandages impregnated with pharmaceutical preparations in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; medicated cotton swabs; medical cotton swabs impregnated with pharmaceutical preparations in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; medicinal and therapeutic preparations for the cleaning and debridement of wounds; medical and surgical antiseptic tissues; medical and surgical antiseptic wipes; medical and surgical antiseptic swabs; wound debridement products, namely, antibacterial sprays, washes, cleansers, gauzes, tissues, wipes, and swabs for medical purposes; materials for wound cleansing, namely, antibacterial sprays, washes, cleansers, gauzes, tissues, wipes, and swabs for medical purposes; materials for debridement, namely, antibacterial sprays, washes, cleansers, gauzes, tissues, wipes, and swabs for medical purposes; medical wound dressings for use in cleaning debris from wounds; cleansing pads for medical use; absorbent pads for medical use; medicated cleansing pads; medicated absorbent pads; medicated tissues and wipes; tissues and wipes impregnated with pharmaceutical preparations in the nature of anesthetics, analgesics, anti-inflammatories, antiseptics, and vasoconstrictors; wound debridement pads; pads for wound cleansing; wound pads for medical use; dressings for wound bed preparation and cleansing; pharmaceutical preparations for pain relief, wound cleaning, wound sterilization, and wound healing; chemical preparations for pharmaceutical purposes, namely, for pain relief, wound cleaning, wound sterilization, and wound healing; chemical reagents for pharmaceutical purposes; chemical preparations for pharmaceutical purposes in the form of gels or sprays for pain relief, wound cleaning, wound sterilization, and wound healing; pain-relieving, wound-healing, and sterilising pharmaceutical preparations; topically applied pain-relieving, wound-healing, and sterilising pharmaceutical preparations; chemical preparations containing anaesthetics, local anaesthetics, analgesics, antiseptics or vasoconstrictors for pain relief, wound cleaning, wound sterilization, and wound healing; topically applied chemical preparations for pharmaceutical purposes containing anaesthetics, local anaesthetics, analgesics, antiseptics or vasoconstrictors for pain relief, wound cleaning, wound sterilization, and wound healing; topical pain-relieving gels and sprays; topical wound-healing gels and sprays; topical anaesthetic gels and sprays; topical analgesic gels and spray; topical antiseptic gels and sprays; anaesthetics; local anaesthetics; analgesic preparations; topical analgesics; topical anaesthetics; pharmaceutical preparations for skincare; pharmaceutical preparations for pain relief; topical gel, topical lotion and topically-applied spray for medical and therapeutic treatment of wounds; antiseptics; chemical preparations for pharmaceutical or medical purposes, namely, for treating wounds; pharmaceutical preparations containing anaesthetic agents, antiseptic agents and vasoconstrictors in the form of topically applied lotions, gels or sprays for treating wounds | SECTION 71 - CANCELLED | — |
| 010 | Medical devices, apparatus and instruments for wound treatment and debridement; surgical devices, apparatus and instruments for wound treatment and debridement | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Animal Ethics Pty Ltd
- Other trademarks owned by Animal Ethics Pty Ltd
- Other trademarks owned by Animal Ethics Pty Ltd
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named MEDI-SOLFEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 29, 2026 | C71T | CANCELLED SECTION 71 | — |
| Nov 12, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 13, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 13, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 18, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 30, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 20, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 4, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 3, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 12, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 12, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 27, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 27, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 23, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 7, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 7, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 7, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 21, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 15, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 15, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 15, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 15, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 15, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 25, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 25, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 25, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 4, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 4, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 21, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 6, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 6, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 27, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 26, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 13, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 9, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 4, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |